Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether Pharmaceutical Reference Standards classifiable under HSN 3822 00 90 are covered by Entry No. 80 of Schedule II to Notification No. 1/2017-Integrated Tax (Rate) dated 28.06.2017, or fall under Entry No. 453 of Schedule III.
Analysis: The goods were accepted as reagents and as laboratory reagents falling under HSN 3822 00 90. The dispute turned on whether the expression "all diagnostic kits and reagents" in Entry No. 80 covered every reagent under heading 3822 or only diagnostic kits and diagnostic reagents. Applying the wording of the entry and the principle of ejusdem generis, the entry was held to extend only to diagnostic kits and diagnostic reagents. Since the goods in question were laboratory reagents and not diagnostic reagents, they were not covered by Entry No. 80. Being goods of Chapter 3822 not specifically covered elsewhere in Schedules I, II, IV, V or VI, they were treated as falling under the residuary entry in Schedule III.
Conclusion: Pharmaceutical Reference Standards under HSN 3822 00 90 are not covered by Entry No. 80 of Schedule II and are covered by Entry No. 453 of Schedule III, attracting IGST at 18%.